Ozempic is an FDA-approved prescription medication used to manage blood sugar in adults with Type 2 diabetes, and while it carries real benefits for many patients, it has also been linked to serious reported side effects, including gastroparesis and bowel obstruction, which is why understanding both sides of the picture matters before you or a family member starts treatment.
You may have heard of Ozempic, the drug that has become widely known partly because of its increasing off-label use for weight loss, or perhaps you already take Ozempic yourself. This page breaks down what Ozempic is, how it works, the risks that have been reported, and where things currently stand with the medication’s regulatory history.
Is Ozempic for Weight Loss?
Ozempic is an FDA-approved prescription medication that belongs to a class of drugs called glucagon-like peptide-1 receptor agonists, or GLP-1 RAs for short. In essence, the drug is intended to mimic a naturally occurring hormone, GLP-1, which helps your body release enough insulin to properly control blood sugar levels. These drugs work by activating the same receptors in your body as GLP-1, which can help individuals with Type 2 diabetes manage blood sugar levels more consistently than some other treatment options.
Other drugs, such as Rybelsus and Wegovy, use the same active ingredient as Ozempic, semaglutide, to produce similar results. Other active ingredients used as GLP-1 receptor agonists include dulaglutide (marketed as Trulicity) and tirzepatide (marketed as Mounjaro).
How Ozempic Works
Ozempic is a once-weekly injectable medication that works by mimicking glucagon-like peptide-1 (GLP-1), a hormone that plays a role in regulating blood sugar. When you take Ozempic, it stimulates the pancreas to produce more insulin, which helps lower blood sugar levels, and it reduces the release of glucagon, a hormone that typically raises blood sugar. This dual action is part of why the drug is also associated with weight loss in many patients, even though weight loss is not its FDA-approved use.
Can Ozempic Be Used for Chronic Weight Management?
Studies have found that GLP-1 drugs slow how fast the stomach empties food, which can make people feel full longer, and some patients lose weight as a result when combined with lifestyle changes. In 2021, Wegovy, which uses the same active ingredient as Ozempic, was approved by the FDA specifically for chronic weight management, the first medication to receive that approval since 2014. Wegovy and Ozempic are the same underlying medication approved for different uses. Ozempic itself remains approved only for Type 2 diabetes management, and its use for weight loss is considered off-label.
Benefits and Risks of Ozempic
Ozempic offers documented benefits for individuals with Type 2 diabetes. It has been shown to improve blood sugar control, aid in weight loss, and reduce the risk of major adverse coronary events in some patient populations. These benefits make it a widely prescribed option for managing diabetes and body weight together.
Like any medication, however, Ozempic carries potential risks. Common, typically short-term side effects include:
- Nausea, vomiting, and diarrhea
- Constipation and abdominal discomfort
- Injection-site reactions
More serious reported side effects include pancreatitis, thyroid tumors, gallbladder disease, bowel obstruction, and multiple endocrine neoplasia. It is essential to discuss these risks with a healthcare provider before starting Ozempic, and to report new or worsening symptoms promptly.
What Do We Know About Ozempic and Gastroparesis?
A growing body of research has examined a possible link between GLP-1 medications and gastroparesis, also called stomach paralysis, a condition in which the stomach empties too slowly. A 2021 study published by Oxford University Press documented gastroparesis with bezoar formation in patients treated with GLP-1 receptor agonists, noting relevance for bariatric and gastric surgery planning.[1] Gastroparesis can contribute to persistent nausea and vomiting, acid reflux, and the development of stomach blockages, and in severe cases it can lead to malnutrition, dehydration, and electrolyte imbalances.
Novo Nordisk’s FDA-approved prescribing information for Ozempic listed gastrointestinal side effects as far back as 2017, and the label has been revised multiple times since, including updates in 2020 addressing side-effect disclosures and further updates in 2025 that strengthened pancreatitis and kidney-related warnings and advised against use in patients with severe gastroparesis.[2] As of mid-2026, federal regulators had not added gastroparesis itself as a listed side effect on the U.S. label, even though European regulators have taken additional steps to update semaglutide labeling for related risks.
Where Does the Ozempic Litigation Stand?
Thousands of product liability cases involving Ozempic, Wegovy, Rybelsus, Mounjaro, and Trulicity have been consolidated into a federal multidistrict litigation proceeding, where plaintiffs allege the manufacturers did not adequately warn about risks such as gastroparesis and bowel obstruction. This is a general description of pending litigation and not a promise of any particular result. If you believe a GLP-1 medication caused you serious harm, an attorney can help you understand how evidence in a pharmaceutical injury case is gathered and whether your situation may fit within an existing case or qualify for a mass tort lawsuit.
Safety and Long-Term Use
Ozempic is generally considered appropriate for long-term use in adults with Type 2 diabetes when monitored by a healthcare provider. Clinical trials supporting FDA approval demonstrated safety and effectiveness over defined trial periods, but the long-term effects of extended off-label weight-loss use are still being studied. Ozempic is not a substitute for a healthy lifestyle, and combining it with a balanced diet and regular activity remains part of standard medical guidance. The medication may not be appropriate for patients with a personal or family history of certain thyroid tumors, pancreatitis, or multiple endocrine neoplasia.
What Should You Do If You Experienced Serious Side Effects?
If you have experienced gastroparesis, a bowel obstruction, gallbladder disease, or another serious complication after taking Ozempic or a similar GLP-1 medication, documenting your medical history and treatment records early can matter. Keep records of when you started the medication, when symptoms began, and every related visit to a healthcare provider, since this timeline often becomes central to evaluating a potential claim.
Why Choose Hollis Law Firm for Your Case?
With over 15 years of experience in pharmaceutical injury law, we combine legal knowledge with an understanding of the science behind prescription drug and medical device litigation, and we stay informed on developments in the Ozempic litigation as they unfold.
At Hollis Law Firm, we work to ensure that individuals harmed by medications such as Ozempic have their concerns heard and evaluated. Reach out to us today to discuss your situation by completing our contact form.
Frequently Asked Questions About Ozempic Safety
Is Ozempic FDA-approved for weight loss?
No. Ozempic is FDA-approved only for managing blood sugar in adults with Type 2 diabetes. Its use for weight loss is considered off-label, while Wegovy, which contains the same active ingredient, is the version specifically approved for chronic weight management.
What is gastroparesis and how does it relate to Ozempic?
Gastroparesis is a condition in which the stomach empties food too slowly, causing nausea, vomiting, and in severe cases malnutrition or dehydration. Research has examined a possible connection between GLP-1 medications like Ozempic and gastroparesis, and the current U.S. label advises against use in patients who already have severe gastroparesis.
What should I do if I have symptoms after taking Ozempic?
Contact your healthcare provider promptly if you notice persistent nausea, vomiting, severe abdominal pain, or other concerning symptoms. Keeping a record of when symptoms started in relation to your dosing schedule can help both your medical care and any later evaluation of a potential legal claim.
Is there ongoing litigation involving Ozempic?
Yes. Thousands of cases involving Ozempic and related GLP-1 medications have been consolidated into a federal multidistrict litigation proceeding, where plaintiffs raise claims related to inadequate warnings about gastrointestinal risks. No trials, verdicts, or settlements had been reached as of this writing.
Can I still take Ozempic if I have a history of pancreatitis?
Ozempic’s prescribing information advises caution in patients with a personal or family history of pancreatitis or certain thyroid conditions. This decision should always be made with your prescribing physician, who can weigh your specific medical history against the potential benefits.
References:
[1] V. Preda, S. S. Khoo, T. Preda, and R. V. Lord, “Gastroparesis with bezoar formation in patients treated with glucagon-like peptide-1 receptor agonists: potential relevance for bariatric and other gastric surgery,” Oxford University Press, Feb. 2021. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC9891341/
[2] Novo Nordisk, “Highlights of Prescribing Information,” U.S. Food and Drug Administration, Drugs@FDA. Available: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209637s003lbl.pdf
